Review Article

Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma

Author(s):

Anshul Kumar, Rohit Bhatia, Pooja Chawla , Durgadas Anghore , Vipin Saini and Ravindra K. Rawal *   Pages 1158 - 1172 ( 15 )

Abstract:

Lymphoma refers to a specialized category of blood cancers, which is characterized by lymph node enlargement, reduced body weight, prolonged tiredness, and fever associated with sweats. Traditional treatment strategies involve chemotherapy, radiation therapy, targeted therapy, and surgery. Copanlisib has emerged as a very potent drug which acts through inhibiting PI3K enzyme. The FDA has approved it for specific treatment of follicular Lymphoma in September 2017. Copanlisib induces tumor cell death along with the prevention of proliferation of dominant malignant β-cells. Copanlisib has a large volume of distribution i.e., 871L (%CV 47.4), plasma protein binding up to 15.8%, plasma half-life(t1/2) of 39.1h and the mean systemic plasma clearance 18.9 L/h (%CV 51.2). In the present review, various aspects related to Copanlisib have been summarized, which include pathophysiology, synthetic strategy, pharmacokinetics, pharmacodynamics and clinical studies. A special emphasis is paid on various reported adverse effects and in silico/in vivo studies conducted on Copanlisib.

Keywords:

Lymphoma, PI3K, copanlisib, systemic plasma clearance, lymph node enlargement, blood cancer.

Affiliation:

Department of Pharmaceutical Chemistry & Analysis, Indo-Soviet Friendship College of Pharmacy, Ferozepur G.T. Road, Moga-142 001, Punjab, Department of Pharmaceutical Chemistry & Analysis, Indo-Soviet Friendship College of Pharmacy, Ferozepur G.T. Road, Moga-142 001, Punjab, Department of Pharmaceutical Chemistry & Analysis, Indo-Soviet Friendship College of Pharmacy, Ferozepur G.T. Road, Moga-142 001, Punjab, Department of Pharmaceutical Chemistry & Analysis, Indo-Soviet Friendship College of Pharmacy, Ferozepur G.T. Road, Moga-142 001, Punjab, Maharishi Markandeshwar University, Solan-173229, Himachal Pradesh, Department of Chemistry, Maharishi Markandeshwar (Deemed to be University), Mullana-133207, Haryana

Graphical Abstract:

Read Full-Text article